Biotech Business Week articles from April 2004

Biotech Business Week archives from April 2004

Uniquely tagged NS5B identifies specific inhibitors of HCV polymerase.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Uniquely tagged NS5B identifies specific inhibitors of HCV polymerase. According to published research from Canada, "the interaction of the hepatitis C virus (HCV) RNA-dependent RNA polymerase with...

Orally active fusion inhibitor of respiratory syncytial virus developed.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Scientists have developed an orally active fusion inhibitor of respiratory syncytial virus. According to recent research from the United States, "BMS-433771 was found to be a potent inhibitor of...

LSBC enters research phase for development of atherosclerosis therapeutic.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Large Scale Biology Corp.'s (LSBC) exclusive license agreement with Cincinnati (Ohio) Children's Hospital Medical Center for the development of a drug to treat a leading cause of death in the U.S. has...

ADA responds to study citing obesity close to being leading cause of death.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- A new study released by the U.S. Centers for Disease Control and Prevention (CDC) shows that deaths due to poor diet and physical inactivity rose by 33% over the past decade and may soon overtake...

Autoimmune disease drug maker completes raises $57 million.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Aspreva Pharmaceuticals Corporation announced the completion of a $57 million private equity financing. Sprout Group, one of the oldest and largest U.S. institutional venture capital firms and an...

Interpore International, Inc., to be acquired.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Interpore International (BONZ) announced that it has entered into a definitive agreement with Biomet, Inc., (BMET) under which Biomet will acquire all of the outstanding common stock of Interpore for...

GNF acquires TrueClone collection.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- OriGene Technologies, Inc., announced the purchase of the TrueClone Collection of more than 20,000 nonredundant full-length human cDNA clones by the Genomics Institute of the Novartis Research...

FDA clears LaparoShield system for minimally invasive abdominal surgery.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Pall Corporation (PLL) announced U.S. Food and Drug Administration (FDA) clearance to market its new LaparoShield Conditioned Insufflation Gas (CIG) System. By conditioning the carbon dioxide...

Lovenox effective in non-ST-elevation acute coronary syndromes, study shows.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- The results of a landmark, 10,027-patient study show that Lovenox (enoxaparin sodium injection) is as effective as unfractionated heparin (UFH) in the treatment of high-risk patients with...

Cloretazine receives Fast Track designation from FDA.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Vion Pharmaceuticals, Inc., (VION) has received Fast Track designation from the U.S. Food and Drug Administration (FDA) for Cloretazine (VNP40101M) in relapsed or refractory acute myeloid leukemia...

Positive results announced for long-term study of Zeatin.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Senetek PLC (SNTK) announced uniformly positive results for its multi-faceted study of the effects of its patented adenine derivative Zeatin on human skin cells. The study, conducted at the...

Manufacture of validation batches for allergy drug completed.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Elite Pharmaceuticals, Inc., (ELI) announced completion of the manufacture of validation batches for a once-a-day product that treats allergies and the symptoms of allergies. The product was...

Test kit launched to check for residential indoor allergens.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- American Home Laboratories, Inc., (AHL) announced the launch of AllergenREPORT, a home test kit that screens for elevated levels of residential indoor allergens, including dust mite, cockroach, cat, and...

Clearant process-treated allografts reduce risk of infection, study shows.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Clinical findings presented at the annual meeting of the American Association of Orthopedic Surgeons showed that patients who received human tissue allograft implants that were treated with a new...

Oral formulation of Fasudil improves stable angina in study patients.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Schering AG, Germany, (SHR) announced that study patients with stable angina receiving the oral formulation of fasudil showed an improvement in oxygen delivery to the heart. Fasudil, which Schering...

Foradil Certihaler receives first European approval.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- SkyePharma PLC (SKYE, SKP) announced that the Swiss pharmaceutical regulatory authority has approved Foradil Certihaler (formoterol fumarate inhalation powder). Foradil Certihaler was codeveloped by...

Study demonstrates Metadate CD has greater effect than Concerta.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- A study published in the March 2004 online issue of Pediatrics comparing the effects of two extended-release methylphenidate formulations in children with attention deficit hyperactivity disorder (ADHD)...

Company helps hospitals, manufacturers respond to new FDA rules.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- AmerisourceBergen Corporation (ABC), a pharmaceutical services company, said it has the broadest array of solutions to help pharmaceutical manufacturers and hospitals respond to the U.S. Food and Drug...

Milestone payments received, first patients treated with Prolieve.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Celsion Corp. (CLN) announced that it has fulfilled the milestone obligations included in its distribution agreement with Boston Scientific Corporation, under which Boston Scientific will market...

$5.9M contract awarded for development of biowarfare technology.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Acacia Research Corporation (CBMX, ACTG) announced that its CombiMatrix Group has received a 2-year contract from the U.S. Department of Defense (DOD) that will provide $5.9 million to further the...

Biosensor rapidly identifies broad-range of infectious organisms.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- RoboDesign International, Inc., has entered into an agreement with Isis Pharmaceuticals' Ibis program to design, develop, and manufacture commercial-ready, self-contained systems for the identification...

Positive phase Ib/II clinical trial results reported for Hemospan.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Sangart, Inc., announced positive results from its phase Ib/II clinical trial involving Hemospan (MP4), a hemoglobin-based oxygen carrier designed to serve as an alternative for blood transfusions. ...

Skeletal imaging agent approved by FDA.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Draximage, Inc., the radiopharmaceutical subsidiary of Draxis Health, Inc., (DRAX) (DAX), has received approval from the U.S. Food and Drug Administration (FDA) to produce and market a new formulation...

Allomatrix Injectable Putty receives FDA clearance.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Wright Medical Group, Inc., (WMGI) announced receipt of marketing clearance from the U.S. Food and Drug Administration (FDA) for its Allomatrix Injectable Putty containing demineralized bone matrix. ...

Hudson licenses radiosensitizer IPdR.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Hudson Health Sciences, Inc., (HHS), a biopharmaceutical company headquartered in San Francisco, California, has licensed IPdR, a radiosensitizer, from Yale University and The Research Foundation of the...

Breast cancer patients switched to Aromasin more likely to remain cancer free.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Post-menopausal breast cancer patients who switched from tamoxifen to Aromasin (exemestane tablets) had a significantly reduced chance of recurrence and increased disease-free survival compared to...

Caelyx demonstrates efficacy, reduced cardiac toxicity.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Schering-Plough Europe reported that results of a randomized phase III clinical study demonstrated that Caelyx (pegylated liposomal doxorubicin hydrochloride) provided comparable efficacy in the...

Lamivudine helps keep HBV at bay during cancer chemotherapy.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Researchers in Hong Kong have discovered a way to help prevent the reactivation of the hepatitis B virus (HBV) in women who are being treated with chemotherapy for breast cancer. Winnie Yeo, an...

NDA filed with FDA for nanoparticle-based Abraxane.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- American Pharmaceutical Partners, Inc., (APP, APPX) and American BioScience, Inc., (ABI) announced that ABI has completed the filing of a New Drug Application (NDA) to the U.S. Food and Drug...

Preoperative treatment with anastrozole reduces need for extensive surgery.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- New data presented at EBCC 2004 indicate that preoperative (neoadjuvant) treatment with anastrozole (Arimidex; AstraZeneca) results in clinically beneficial reductions in tumor volume, extending the...

Results of comparison study favor exemestane for advanced disease.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- The first results from the only Phase III trial to compare tamoxifen with the newer hormone treatment exemestane in advanced breast cancer shows that exemestane is safe, superior, and lengthens...

Avelox shows clinical success for acute exacerbations of chronic bronchitis.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- A new study shows patients with acute exacerbations of chronic bronchitis (AECB) who took a 5-day course of the antibiotic Avelox (moxifloxacin HCl) achieved a greater clinical cure rate than patients...

Factive receives marketing approval in Canada, ready for U.S. launch.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Genome Therapeutics Corp. (GENE) has received marketing approval for Factive (gemifloxacin mesylate) tablets for the treatment of acute bacterial exacerbations of chronic bronchitis from the Therapeutic...

$1.7M award for cardiac safety monitoring and services announced.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- eResearchTechnology, Inc., (eRT) has been awarded studies totaling approximately $1.7 million in cardiac safety monitoring and services from a top 15 global pharmaceutical organization under a...

Biotechnology company announces Form 15 filing.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Protide Pharmaceuticals, Inc., (PPMD) announced the filing of a Form 15 with the U.S. Securities and Exchange Commission (SEC) to terminate registration of Protide Pharmaceuticals' common stock under...

Biotechnology company announces series B financing and new appointments.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Phylogix, Inc., announced that that it has secured $12 million in series B financing. Leading the round were top-tier venture capital firms Radius Ventures, Atlas Venture, Prospect Venture Partners,...

Initial letter agreement announced for adult stem cell bank.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Phase III Medical, Inc., (PHSM) has entered into an initial letter agreement to finalize a revenue sharing agreement with NeoStem, Inc. NeoStem will create adult stem cell banks and offer the...

Pharmaceutical companies spend over $900M on cholesterol drugs, study shows.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Pharmaceutical companies allocate an average cross-functional budget of $933 million to support cholesterol-lowering drugs, according to a new study launched by Cutting Edge Information. ...

Company moves to establish new spine distribution network.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- ArthroCare Corp. (ARTC), a multi-business medical device company that develops products based on its patented Coblation technology, announced a new business strategy designed to expand the company's...

Diagnostics company establishes customer care subsidiary.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Diagnostic Ultrasound Corporation announced the creation of a new customer care subsidiary. The Diagnostic Ultrasound Customer Care Corporation was created to improve the company's business...

Nanotechnology drug developer reports key achievement.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- BioSante Pharmaceuticals (BPA) announced key achievements and financial results for the year ended December 31, 2003. "We are quite pleased with our achievements and progress in the last year....

Pharmacogenomics company establishes U.K. subsidiary.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Gene Logic, Inc., (GLGC) has established Gene Logic, Ltd., a wholly owned subsidiary based in the United Kingdom, that will facilitate sales, marketing, and customer support in Europe for the company's...

State gives Kaiser only part of its requested rate increase.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Hawaii's Insurance Division has given Kaiser Foundation Health Plan only part of its requested 14.5% rate increase. The state agency has suggested an increase in the range of 11.5% to 11.7%. ...

Commercial agreement announced for cancer vaccine product candidate.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Prima BioMed Ltd, subsidiary CancerVac, and Biomira Inc. (BIOM) announced a commercial agreement for the development and commercialization of CancerVac's most advanced cancer vaccine product candidate....

Diagnostic tool enables analysis of molecular characteristics of breast tumors.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Significant progress towards identifying the genetic make-up of individual tumors, hence allowing treatment choices to be made based on personalized information, was announced at the 4th European Breast...

Pharmaceutical plant workers have no excess mortality.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- A study of pharmaceutical plant employees found no pattern of excess mortality over a 50-year period. "An historical cohort study was conducted of workers at a pharmaceutical manufacturing plant....

FDA gives market clearance for cardiac stimulation system.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- EP MedSystems, Inc., (EPMD) said the U.S. Food & Drug Administration (FDA) provided market clearance for its new EP-4 Computerized Cardiac Stimulator. The EP-4 offers further advancements in cardiac...

Cardiac MRI a better predictor of heart attack, death for women.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- The use of non-invasive cardiac magnetic resonance imaging (MRI) appears to be more effective than conventional diagnostic procedures, such as nuclear stress testing and coronary angiography, in the...

ThinPrep launched at Pacific Rim Pathology Laboratory.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Cytyc Corporation (CYTC) announced that Pacific Rim Pathology Laboratory in San Diego, California, has implemented the ThinPrep Imaging System. Pacific Rim has been offering the ThinPrep Pap Test...

Aloxi injection incorporated into NCCN antiemetic guidelines.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- MGI Pharma, Inc., (MOGN) announced that Aloxi (palonosetron hydrochloride) injection has been incorporated into the 2004 National Comprehensive Cancer Network (NCCN) antiemetic guidelines for prevention...

Database offers secure, long-term storage of chromatography data.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Varian, Inc., (VARI) introduced a new option for its successful Galaxie Chromatography Data System, called the Galaxie DataBase, which offers the option to collect and store chromatographic data in a...

FDA approves Sensipar for the treatment of secondary hyperparathyroidism.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Amgen, Inc., (AMGN) announced that the U.S. Food and Drug Administration (FDA) approved Sensipar (cinacalcet HCl) following a priority review. Sensipar, an innovative, first-in-class oral...

Preliminary results of Xcytrin for chronic lymphocytic leukemia announced.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Pharmacyclics, Inc., (PCYC) announced the presentation of preliminary results from its ongoing, recently initiated, phase II trial evaluating Xcytrin (motexafin gadolinium) Injection as a single agent...

Enrollment status announced for Oxytrex phase III study.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Pain Therapeutics, Inc., (PTIE) has enrolled more than 350 patients in its first phase III study with Oxytrex, an oral painkiller being developed by the company to treat severe chronic pain. "This...

Agreement signed for Canadian distribution of dermatology products.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Atrix Laboratories, Inc., (ATRX) announced that the company has signed an exclusive marketing agreement with Genpharm for the distribution of specific generic topical dermatology products in Canada. ...

Agreement signed with Gilead Sciences for use of Captisol.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- CyDex, Inc., announced that it has entered into a limited use agreement with Gilead Sciences, Inc., for CyDex's advanced formulation system Captisol. Captisol enables the safe, effective delivery of...

Alliance partners to accelerate development of drug-eluting stent.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- CardioTech International, Inc., (CTE) and Implant Sciences Corporation (IMX.WS) jointly announced that they have joined with CorNova, Inc., to develop and market a new generation drug-eluting stent...

Alliance to focus on cancer drug study.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- ChromaVision Medical Systems, Inc., (CVSN), a provider of automated cell-imaging systems and manufacturer of the ACIS digital microscope system, announced that it has entered into a clinical research...

Company expands pipeline to include obesity, oncology therapies.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Gilles Gagnon, president and CEO at AEterna Laboratories, Inc., (AEL; AELA), presented the company's extensive product pipeline in oncology, endocrinology, and infectious diseases at the Bio Square 2004...

Genaera extends alliance IL-9 alliance.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Genaera Corp. (GENR) and the Ludwig Institute for Cancer Research (LICR) announced a 2-year extension of a collaborative agreement on the joint discovery and development of novel genes and proteins as...

Partnership to advance high-tech genomics research.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Children's Memorial Institute for Education and Research and The Translational Genomics Research Institute (TGen), of Phoenix, Arizona, announced a partnership aimed at conducting cutting-edge genomic...

Pharmaceutical firms expand siRNA supply agreement.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Dharmacon, Inc., a supplier of innovative RNA and RNA interference (RNAi) research products, announced an expansion of its existing agreement to supply custom siRNA reagents to Bayer Pharmaceuticals...

Researcher signs siRNA deal to enhance obesity, diabetes program.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- CytRx Corporation (CYTR) said a collaboration recently announced between the University of Massachusetts Medical School (UMMS) and Dharmacon, Inc., will enhance and accelerate the work being done under...

Three-year laparoscopic instrument agreement signed with Premier.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Aesculap, Inc., announced the award of an agreement with Premier Purchasing Partners for laparoscopic instruments. The Aesculap/Premier contract portfolio now includes laparoscopic instruments,...

Cancer-care services company announces participation in colon cancer trials.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- A breakthrough treatment for advanced-stage colorectal cancer represents a milestone in research that will have significant benefits for patients, say US Oncology, Inc., (USON), network physicians...

Phase II colorectal vaccine trial results updated.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Biomira, Inc., (BIOM, BRA) provided an update of data from the phase II Theratope vaccine colorectal study of 20 patients. A Kaplan-Meier Survival and Time to Disease Progression Curve of the 20...

Report: Injectable products propel growth in $1.2B aesthetics market.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Medtech Insight, LLC, in a new report entitled "The U.S. Aesthetics Marketplace," details the U.S. markets for surgical and nonsurgical cosmetic surgery products, including topical and injectable...

$1M in grants to fund cytomegalovirus vaccine development.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Vical Incorporated (VICL) has received notification of funding of approximately $1 million for research and development related to the company's plasmid DNA vaccine against cytomegalovirus (CMV) under...

Perindopril reduces cardiovascular death and heart attack risk in diabetes study.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- The long-acting ACE inhibitor perindopril (Coversyl) appears to reduce the risk of cardiovascular death and heart attacks in diabetic patients with stable coronary disease already receiving standard...

Diabetes development in spontaneously diabetic Torii rats described.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Researchers have characterized the development of diabetes in male spontaneously diabetic Torii rats in a recent issue of Biochemical and Biophysical Research Communications. "To characterize the...

IDPc inhibitor has anti-diabetic effects in mice fed high-sucrose diet.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- A synthetic IDPc inhibitor demonstrated anti-diabetic effects in C57BU6J mice fed a high-fat, high-sucrose diet. According to recent research from South Korea, "DA-11004 is a synthetic, potent...

ProteinChip system receives medical device certification in China.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- The Ciphergen Diagnostics Division of Ciphergen Biosystems, Inc., (CIPH) announced that the ProteinChip System has been certified (certificate number SFDA(I) 20032400768) by the State Food and Drug...

Drug benefits clients beat national drug cost trend.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- A drug trends "scorecard" published by AdvancePCS (ADVP) reveals an impressive tally by health plan sponsors that have aggressively employed pharmacy benefit management tools to slow rising prescription...

Complete genome sequence of Saccharopolyspora erythraea reported.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Aventis Bulk S.p.A. has successfully sequenced the whole genome of Saccharopolyspora erythraea. The strain is an industrial overproducer of erythromycin antibiotic. The work was carried out in...

Collaboration results in initiation of human trials for inflammatory indication.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Pharmacopeia, Inc., (ACCL) announced that Schering-Plough Corporation (SGP) has initiated human trials of a compound for an inflammatory indication discovered through collaboration between the...

Commercial protein purification program to accelerate drug discovery.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Purely Proteins Ltd announced the initiation of its commercial protein purification program designed to accelerate and enhance the drug discovery and development process. The first products from...

Milestone achieved in informatics collaboration.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Tripos, Inc., (TRPS) announced the completion of a significant milestone in its ongoing discovery informatics collaboration with Schering AG. Schering has accepted Tripos' Auspyx data cartridge for...

Weight loss and decreased waist size shown in rimonabant dyslipidemia study.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Results of a phase III clinical trial (RIO-Lipids or Rimonabant In Obesity) comparing rimonabant, the first drug in a new class called selective CB1 blockers (SCB1Bs), to placebo found that overweight...

FDA approves once-daily Floxin Otic (ofloxacin otic solution).
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Daiichi Pharmaceutical Corporation announced the recent approval by the U.S. Food and Drug Administration (FDA) of a once-daily for 7 days dosing regimen of Floxin Otic (ofloxacin otic solution) 0.3%, a...

Phenytoin Oral Suspension receives FDA approval for treatment of epilepsy.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Taro Pharmaceutical Industries Ltd. (TARO) reported that its U.S. affiliate has received approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for...

Majority of patients taking Levitra report satisfaction.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- According to the results of recent survey data, both patients and physicians are reporting satisfaction with the erectile dysfunction treatment Levitra. Ninety-four percent of the 240 surveyed...

Topical therapy can be effective in patients with impotence.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- NexMed, Inc., (NEXM), a developer of transdermal treatments based on the NexACT drug delivery technology, announced that an article positioning Alprox-TD as a potential first choice alternative for...

U.S. orphan drug designation granted for AT1001.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Amicus Therapeutics, Inc., an emerging drug development company focused on the development of a novel therapeutic approach to the treatment of human genetic disorders, with an initial focus on lysosomal...

$10.4 million raised in private placement of common stock.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- ThermoGenesis Corp. (KOOL) has completed a private placement of 2.6 million shares of common stock at a price of $4.00 per share. All of the shares were sold by the company. Upon closing, the...